I think those are all valid comments.
I've been invested in this company since March 2021 at which point everything seemed like it was 'about to happen' but then it 'appeared' collapse after Kwinana. That Q&A recently posted and the comms just announced now make it clearer as to what was and is planned and it appears that the company is aiming to be 'operational' by 2025/26 which seems reasonable to me.
In regards to the performance bonuses though, there should be no more going forward unless they are linked to either achievable positive financial targets such as funding secured for approved development projects or production milestones - Epanko phase 1 etc. If there is further 'generous' performance bonuses proposed in the next AGM with little or no metrics around them, I will be thinking seriously about a no vote on remuneration.
Not intended as financial advice - DYOR
- Forums
- ASX - By Stock
- General Discussion
EGR
ecograf limited
Add to My Watchlist
1.75%
!
28.0¢

I think those are all valid comments. I've been invested in this...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
28.0¢ |
Change
-0.005(1.75%) |
Mkt cap ! $127.1M |
Open | High | Low | Value | Volume |
28.5¢ | 28.5¢ | 27.0¢ | $73.01K | 264.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 7272 | 27.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
28.5¢ | 14597 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 7272 | 0.275 |
1 | 3700 | 0.270 |
3 | 93700 | 0.265 |
2 | 5423 | 0.260 |
2 | 11176 | 0.255 |
Price($) | Vol. | No. |
---|---|---|
0.285 | 14597 | 1 |
0.290 | 76322 | 3 |
0.295 | 147922 | 4 |
0.300 | 64300 | 5 |
0.305 | 3000 | 1 |
Last trade - 15.16pm 27/06/2025 (20 minute delay) ? |
Featured News
EGR (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online